{"SPADE_N_06493": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06493", "Peptide Name": "LysH", "Source": "porcine cathelicidin peptide", "Family": "", "Gene": "Not found", "Sequence": "RAWVAWR", "Sequence Length": 7, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:Jurkat (IC50 ≥ 65 µM)", "Hemolytic Activity": "RBC:IC50 ≥ 65 µM", "Cytotoxicity": "PBMC:IC50 ≥ 65 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C45H65N15O8", "Mass": 944.09, "PI": 12.0, "Net Charge": 2, "Hydrophobicity": -0.43, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8)183228.", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32126228"}], "Frequent Amino Acids": "ARW", "Absent Amino Acids": "CDEFGHIKLMNOPQSTUY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 5, "Polar Residues": 5, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_11023", "Similarity": 1.0, "Sequence": "RAWVAWRNR"}, {"SPADE_ID": "SPADE_N_13536", "Similarity": 1.0, "Sequence": "KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV"}, {"SPADE_ID": "SPADE_N_14164", "Similarity": 1.0, "Sequence": "AGTEKIFQRLKKTIQEGKKIAKRAW"}]}}}